Riskpilot← Back to searchSign inGet full accessCellart Aktiebolag
ABActiveOrg 5560835737Sigtunagatan 10General medical practice activities · NACE 8621Est. 19621 employees
Revenue 2024
SEK 0
EBITDA margin
—
0% vs 2023
Equity ratio
86.8%
Financial strength
Net profit 2024
SEK 44K
-40% vs 2023
| Revenue | SEK 0 | — |
| EBITDA | SEK -20K | +0% |
| Net profit | SEK 44K | -40% |
| Total assets | SEK 189K | -36% |
| Equity | SEK 164K | -15% |
| Employees | 1 | — |
Legal name
Cellart Aktiebolag
Org number
5560835737
Legal form
Aktiebolag
NACE code
8621 · General medical practice activities
Founded
23 juli 1962
Share capital
SEK 100 000
Employees
1 (FTE)
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Aktiebolaget ska driva medicinsk konsultation, äga och förvalta egendom samt bedriva handel med konst.
Address
Sigtunagatan 10
Phone
+46707155835
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 0 | 0 |
| Staff expenses | — | — | — | — | — |
| EBITDA | 16 | −34 | −27 | −20 | −20 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −0 |
| EBIT | 16 | −34 | −27 | −20 | −20 |
| Net financials | −109 | −33 | −77 | — | — |
| Profit before tax | 63 | 83 | 72 | 94 | 56 |
| Tax | −18 | −21 | −19 | −21 | −12 |
| Net profit | 45 | 62 | 53 | 73 | 44 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 760 | 624 | 470 | 295 | 189 |
| Equity | 166 | 183 | 174 | 193 | 164 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 78 | 76 | 106 | 26 | 25 |
| Total debt | 78 | 76 | 106 | 26 | 25 |
EBITDA margin
-2000000.0%
This company
15.8%
Market median
-12658328% vs market
20202024
Equity ratio
86.8%
This company
38.2%
Market median
+127% vs market
20202024
Return on equity
26.8%
This company
18.4%
Market median
+46% vs market
20202024
Net profit margin
4400000.0%
This company
8.1%
Market median
+54320888% vs market
20202024
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20202024
Debt / equity
0.15×
This company
0.62×
Market median
+76% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Former (1) | ||
GR Audit | Audit | 2020 – 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Deputy Board Member | 2021 | |
| Board of Directors | 2020 | |
| Former (1) | ||
| Deputy Board Member | 2020 – 2021 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Cellart Aktiebolag also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Göran Roger Berg | Audit | 0 companies |
| Janusz Kasina | Deputy Board Member | 0 companies |
| Agnieszka Zysk | Deputy Board Member | 0 companies |
| Mariusz Wisniewski | Board of Directors | 0 companies |